Prognostic factors identified three risk groups in the LRF CLL4 trial independent of treatment allocation

摘要

BackgroundMany prognostic markers have been identified in chronic lymphocytic leukemia, but there have been few opportunities to assess their relative importance in a large randomized trial. The aim of this study was to determine which of the available markers independently predicted outcome in patients requiring treatment and to use these to define new risk groups.